Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mark Rachesky Further Increases Stake In Titan International Inc (TWI)

Mark Rachesky is still bullish on Titan International Inc (NYSE:TWI) and has further increased his fund’s activist stake in the company. According to a recent Form 4 filing with the Securities and Exchange Commission, Rachesky’s fund, MHR Fund Management, has acquired 490,775 shares in 9 transactions at prices varying between $14.11 and $14.99 per unit. Following this move, Rachesky and MHR, have amassed 7.5 million shares of Titan International Inc (NYSE:TWI).

Titan International Inc (NYSE:TWI)

Billionaire Ken Griffin is extremely bullish on this stock, having increased his fund’s holding by 41027% during the first quarter of 2014. In its latest 13F filing, Citadel Investment Group reported ownership of approximately 555,200 shares. Robert Rodriguez and Steven Romick, the managers of First Pacific Advisors LLC, are also fans of Titan International Inc (NYSE:TWI), having increased their holding of the stock by 83% to 1.55 million shares. Jay Petschek and Steven Major are not so optimistic and have deemed it wise to reduce their stake in the company. Their fund, Corsair Capital Management, reportedly holds 425,600 shares of Titan International Inc (NYSE:TWI) in its equity portfolio.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!